Novocure and Verastem to Evaluate Pancreatic Cancer Combination Therapy
Novocure said it entered into a clinical arrangement with Verastem to evaluate combination therapy for pancreatic cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Novocure, Verastem Oncology to Evaluate Combination Therapy for Pancreatic Cancer
Novocure and Verastem Oncology will evaluate a combination therapy for pancreatic cancer.